The Biotech Growth Trust PLC (BIOG) — Net Asset Quality Index
The Biotech Growth Trust PLC (BIOG) has a Net Asset Quality Index of 88.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX289.97 Million minus total liabilities of GBX32.10 Million yields net assets of GBX257.88 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore total assets of The Biotech Growth Trust PLC for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
The Biotech Growth Trust PLC Net Asset Quality Index Over Time (2004–2025)
This chart shows how The Biotech Growth Trust PLC's Net Asset Quality Index has evolved across 22 annual periods from 2004 to 2025. As of September 2025, the index stands at 88.9%, representing net assets of GBX257.88 Million against total assets of GBX289.97 Million GBX. See BIOG working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for The Biotech Growth Trust PLC (2004–2025)
The table below presents the year-by-year Net Asset Quality Index for The Biotech Growth Trust PLC from 2004 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see The Biotech Growth Trust PLC market capitalisation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.6% | GBX221.21 Million | GBX226.63 Million | GBX5.42 Million | ▲ +9.8 pp |
| 2024 | 87.8% | GBX361.31 Million | GBX411.42 Million | GBX50.11 Million | ▼ -3.8 pp |
| 2023 | 91.6% | GBX330.29 Million | GBX360.51 Million | GBX30.22 Million | ▼ -0.6 pp |
| 2022 | 92.2% | GBX394.21 Million | GBX427.45 Million | GBX33.24 Million | ▼ -0.4 pp |
| 2021 | 92.6% | GBX601.47 Million | GBX649.53 Million | GBX48.06 Million | ▲ +1.5 pp |
| 2020 | 91.1% | GBX365.57 Million | GBX401.19 Million | GBX35.62 Million | ▼ -3.7 pp |
| 2019 | 94.8% | GBX408.88 Million | GBX431.23 Million | GBX22.36 Million | ▲ +1.2 pp |
| 2018 | 93.6% | GBX417.40 Million | GBX446.07 Million | GBX28.68 Million | ▼ -3.6 pp |
| 2017 | 97.2% | GBX448.41 Million | GBX461.50 Million | GBX13.08 Million | ▲ +8.1 pp |
| 2016 | 89.0% | GBX378.57 Million | GBX425.14 Million | GBX46.58 Million | ▼ -1.9 pp |
| 2015 | 90.9% | GBX533.30 Million | GBX586.53 Million | GBX53.23 Million | ▲ +1.5 pp |
| 2014 | 89.4% | GBX340.25 Million | GBX380.43 Million | GBX40.19 Million | ▼ -2.2 pp |
| 2013 | 91.7% | GBX244.44 Million | GBX266.66 Million | GBX22.22 Million | ▼ -4.8 pp |
| 2012 | 96.5% | GBX156.13 Million | GBX161.87 Million | GBX5.74 Million | ▲ +7.1 pp |
| 2011 | 89.4% | GBX120.82 Million | GBX135.20 Million | GBX14.38 Million | ▼ -1.2 pp |
| 2010 | 90.6% | GBX120.42 Million | GBX132.92 Million | GBX12.51 Million | ▼ -3.7 pp |
| 2009 | 94.3% | GBX70.21 Million | GBX74.48 Million | GBX4.28 Million | ▼ -2.8 pp |
| 2008 | 97.0% | GBX64.50 Million | GBX66.47 Million | GBX1.97 Million | ▲ +1.7 pp |
| 2007 | 95.4% | GBX76.80 Million | GBX80.53 Million | GBX3.73 Million | ▲ +1.8 pp |
| 2006 | 93.6% | GBX36.56 Million | GBX39.07 Million | GBX2.51 Million | ▼ -5.5 pp |
| 2005 | 99.0% | GBX30.45 Million | GBX30.74 Million | GBX294.00K | ▲ +0.4 pp |
| 2004 | 98.6% | GBX33.62 Million | GBX34.08 Million | GBX462.00K | — |